Interactions between muscle stem cells, mesenchymal-derived cells and immune cells in muscle homeostasis, regeneration and disease

Cell Death and Disease

Volumn 6, Issue 7, 2015, Pages

  Farup, J ^a   Madaro, L ^b,c   Puri, P L ^b,c   Mikkelsen, U R ^a,d  

^a AARHUS UNIVERSITY   (Denmark)

^b BURNHAM INSTITUTE   (United States)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TISSUE; AGING; CACHEXIA; ENDURANCE TRAINING; EXERCISE; HUMAN; IMMUNOCOMPETENT CELL; INSULIN SENSITIVITY; MESENCHYMAL STEM CELL; METABOLIC DISORDER; MUSCLE DISEASE; MUSCLE HYPERTROPHY; MUSCLE METABOLISM; MUSCLE REGENERATION; MUSCLE STEM CELL; NEUROMUSCULAR DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; ADIPOCYTE; CELL COMMUNICATION; CELL DIFFERENTIATION; CYTOLOGY; DUCHENNE MUSCULAR DYSTROPHY; EOSINOPHIL; FIBROBLAST; HOMEOSTASIS; IMMUNOLOGY; MACROPHAGE; MESENCHYMAL STROMA CELL; METABOLISM; MUSCLE DEVELOPMENT; PATHOLOGY; PHYSIOLOGY; REGENERATION; SKELETAL MUSCLE SATELLITE CELL;

ADIPOCYTES; CELL COMMUNICATION; CELL DIFFERENTIATION; EOSINOPHILS; FIBROBLASTS; HOMEOSTASIS; HUMANS; MACROPHAGES; MESENCHYMAL STROMAL CELLS; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; REGENERATION; SATELLITE CELLS, SKELETAL MUSCLE;

EID: 84954213531     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2015.198     Document Type: Review

References (183)

1. Marquis K, Debigare R, Lacasse Y, LeBlanc P, Jobin J, Carrier G et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166: 809-813.
2. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 2008; 9: 629-635.
3. Langen RC, Gosker HR, Remels AH, Schols AM. Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease. Int J Biochem Cell Biol 2013; 45: 2245-2256.
4. D'Souza DM, Al-Sajee D, Hawke TJ. Diabetic myopathy: impact of diabetes mellitus on skeletal muscle progenitor cells. Front Physiol 2013; 4: 379.
5. Charge SB, Rudnicki MA. Cellular and molecular regulation of muscle regeneration. Physiol Rev 2004; 84: 209-238.
6. Hawke TJ, Garry DJ. Myogenic satellite cells: physiology to molecular biology. J Appl Physiol 2001; 91: 534-551.
7. Joanisse S, Gillen JB, Bellamy LM, McKay BR, Tarnopolsky MA, Gibala MJ et al. Evidence for the contribution of muscle stem cells to nonhypertrophic skeletal muscle remodeling in humans. FASEB J 2013; 27: 4596-4605.
8. Yin H, Price F, Rudnicki MA. Satellite cells and the muscle stem cell niche. Physiol Rev 2013; 93: 23-67.
9. Uezumi A, Fukada S, Yamamoto N, Takeda S, Tsuchida K. Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle. Nat Cell Biol 2010; 12: 143-152.
10. Joe AW, Yi L, Natarajan A, Le Grand F, So L, Wang J et al. Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis. Nat Cell Biol 2010; 12: 153-163.
11. Heredia JE, Mukundan L, Chen FM, Mueller AA, Deo RC, Locksley RM et al. Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration. Cell 2013; 153: 376-388.
12. Mozzetta C, Consalvi S, Saccone V, Tierney M, Diamantini A, Mitchell KJ et al. Fibroadipogenic progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic muscles of young, but not old Mdx mice. EMBO Mol Med 2013; 5: 626-639.
13. Rodeheffer MS. Tipping the scale: muscle versus fat. Nat Cell Biol 2010; 12: 102-104.
14. Uezumi A, Fukada S, Yamamoto N, Ikemoto-Uezumi M, Nakatani M, Morita M et al. Identification and characterization of PDGFRalpha+ mesenchymal progenitors in human skeletal muscle. Cell Death Dis 2014; 5: e1186.
15. Dong Y, Silva KA, Dong Y, Zhang L. Glucocorticoids increase adipocytes in muscle by affecting IL-4 regulated FAP activity. FASE B J 2014; 28: 4123-4132.
16. Saccone V, Consalvi S, Giordani L, Mozzetta C, Barozzi I, Sandona M et al. HDAC-regulated myomiRs control BAF60 variant exchange and direct the functional phenotype of fibro-adipogenic progenitors in dystrophic muscles. Genes Dev 2014; 28: 841-857.
17. Snijders T, Verdijk LB, van Loon LJ. The impact of sarcopenia and exercise training on skeletal muscle satellite cells. Ageing Res Rev 2009; 8: 328-338.
18. Schultz E. Satellite cell proliferative compartments in growing skeletal muscles. Dev Biol 1996; 175: 84-94.
19. Fry CS, Lee JD, Jackson JR, Kirby TJ, Stasko SA, Liu H et al. Regulation of the muscle fiber microenvironment by activated satellite cells during hypertrophy. FASEB J 2014; 28: 1654-1665.
20. Suetta C, Frandsen U, Mackey AL, Jensen L, Hvid LG, Bayer ML et al. Ageing is associated with diminished muscle re-growth and myogenic precursor cell expansion early after immobility-induced atrophy in human skeletal muscle. J Physiol 2013; 591: 3789-3804.
21. McKay BR, Ogborn DI, Bellamy LM, Tarnopolsky MA, Parise G. Myostatin is associated with age-related human muscle stem cell dysfunction. FASEB J 2012; 26: 2509-2521.
22. Lepper C, Partridge TA, Fan CM. An absolute requirement for Pax7-positive satellite cells in acute injury-induced skeletal muscle regeneration. Development 2011; 138: 3639-3646.
23. von Maltzahn J, Jones AE, Parks RJ, Rudnicki MA. Pax7 is critical for the normal function of satellite cells in adult skeletal muscle. Proc Natl Acad Sci USA 2013; 110: 16474-16479.
24. Bruusgaard JC, Johansen IB, Egner IM, Rana ZA, Gundersen K. Myonuclei acquired by overload exercise precede hypertrophy and are not lost on detraining. Proc Natl Acad Sci USA 2010; 107: 15111-15116.
25. Fry CS, Lee JD, Mula J, Kirby TJ, Jackson JR, Liu F et al. Inducible depletion of satellite cells in adult, sedentary mice impairs muscle regenerative capacity without affecting sarcopenia. Nat Med 2015; 21: 76-80.
26. McCarthy JJ, Mula J, Miyazaki M, Erfani R, Garrison K, Farooqui AB et al. Effective fiber hypertrophy in satellite cell-depleted skeletal muscle. Development 2011; 138: 3657-3666.
27. Oishi T, Uezumi A, Kanaji A, Yamamoto N, Yamaguchi A, Yamada H et al. Osteogenic differentiation capacity of human skeletal muscle-derived progenitor cells. PLoS One 2013; 8: e56641.
28. Uezumi A, Ikemoto-Uezumi M, Tsuchida K. Roles of nonmyogenic mesenchymal progenitors in pathogenesis and regeneration of skeletal muscle. Front Physiol 2014; 5: 68.
29. Rao RR, Long JZ, White JP, Svensson KJ, Lou J, Lokurkar I et al. Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis. Cell 2014; 157: 1279-1291.
30. Qiu Y, Nguyen KD, Odegaard JI, Cui X, Tian X, Locksley RM et al. Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell 2014; 157: 1292-1308.
31. Wu D, Molofsky AB, Liang HE, Ricardo-Gonzalez RR, Jouihan HA, Bando JK et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 2011; 332: 243-247.
32. Cordani N, Pisa V, Pozzi L, Sciorati C, Clementi E. Nitric oxide controls fat deposition in dystrophic skeletal muscle by regulating fibro-adipogenic precursor differentiation. Stem Cells 2014; 32: 874-885.
33. Takada S, Okita K, Suga T, Omokawa M, Kadoguchi T, Sato T et al. Low-intensity exercise can increase muscle mass and strength proportionally to enhanced metabolic stress under ischemic conditions. J Appl Physiol 2012; 113: 199-205.
34. Laude K, Favre J, Thuillez C, Richard V. NO produced by endothelial NO synthase is a mediator of delayed preconditioning-induced endothelial protection. Am J Physiol Heart Circ Physiol 2003; 284: H2053-H2060.
35. Rana A, Goyal N, Ahlawat A, Jamwal S, Reddy B, Sharma S. Mechanisms involved in attenuated cardio-protective role of ischemic preconditioning in metabolic disorders. Perfusion 2014; 30: 94-105.
36. Tatsumi R, Hattori A, Ikeuchi Y, Anderson JE, Allen RE. Release of hepatocyte growth factor from mechanically stretched skeletal muscle satellite cells and role of pH and nitric oxide. Mol Biol Cell 2002; 13: 2909-2918.
37. Tatsumi R, Wuollet AL, Tabata K, Nishimura S, Tabata S, Mizunoya W et al. A role for calcium-calmodulin in regulating nitric oxide production during skeletal muscle satellite cell activation. Am J Physiol Cell Physiol 2009; 296: C922-C929.
38. Christov C, Chretien F, Abou-Khalil R, Bassez G, Vallet G, Authier FJ et al. Muscle satellite cells and endothelial cells: close neighbors and privileged partners. Mol Biol Cell 2007; 18: 1397-1409.
39. Muñoz-Cánoves P, Scheele C, Pedersen BK, Serrano AL. Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword?. FEBS J 2013; 280: 4131-4148.
40. Begue G, Douillard A, Galbes O, Rossano B, Vernus B, Candau R et al. Early activation of rat skeletal muscle IL-6/STAT1/STAT3 dependent gene expression in resistance exercise linked to hypertrophy. PLoS One 2013; 8: e57141.
41. Saclier M, Yacoub-Youssef H, Mackey AL, Arnold L, Ardjoune H, Magnan M et al. Differentially activated macrophages orchestrate myogenic precursor cell fate during human skeletal muscle regeneration. Stem Cells 2012; 31: 384-396.
42. Price FD, von Maltzahn J, Bentzinger CF, Dumont NA, Yin H, Chang NC et al. Inhibition of JAK-STAT signaling stimulates adult satellite cell function. Nat Med 2014; 20: 1174-1181.
43. Iezzi S, Di Padova M, Serra C, Caretti G, Simone C, Maklan E et al. Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin. Dev Cell 2004; 6: 673-684.
44. Lee SJ, McPherron AC. Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA 2001; 98: 9306-9311.
45. Akhmedov D, Berdeaux R. The effects of obesity on skeletal muscle regeneration. Front Physiol 2013; 4: 371.
46. Tardif N, Salles J, Guillet C, Tordjman J, Reggio S, Landrier J-F. et al. Muscle ectopic fat deposition contributes to anabolic resistance in obese sarcopenic old rats through eIF2α activation. Aging Cell 2014; 13: 1001-1011.
47. Yim JE, Heshka S, Albu J, Heymsfield S, Kuznia P, Harris T et al. Intermuscular adipose tissue rivals visceral adipose tissue in independent associations with cardiovascular risk. Int J Obes (Lond) 2007; 31: 1400-1405.
48. Sinha R, Dufour S, Petersen KF, LeBon V, Enoksson S, Ma YZ et al. Assessment of skeletal muscle triglyceride content by (1) H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity. Diabetes 2002; 51: 1022-1027.
49. Freda PU, Shen W, Heymsfield SB, Reyes-Vidal CM, Geer EB, Bruce JN et al. Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor I excess due to acromegaly. J Clin Endocrinol Metab 2008; 93: 2334-2343.
50. Aguiari P, Leo S, Zavan B, Vindigni V, Rimessi A, Bianchi K et al. High glucose induces adipogenic differentiation of muscle-derived stem cells. Proc Natl Acad Sci USA 2008; 105: 1226-1231.
51. Kent-Braun JA, Ng AV, Young K. Skeletal muscle contractile and noncontractile components in young and older women and men. J Appl Physiol 2000; 88: 662-668.
52. Baker JF, Von Feldt J, Mostoufi-Moab S, Noaiseh G, Taratuta E, Kim W et al. Deficits in muscle mass, muscle density, and modified associations with fat in rheumatoid arthritis. Arthritis Care Res 2014; 66: 1612-1618.
53. Roig M, Eng JJ, MacIntyre DL, Road JD, Reid WD. Deficits in muscle strength, mass, quality, and mobility in people with chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev 2011; 31: 120-124.
54. Stephens NA, Skipworth RJ, Macdonald AJ, Greig CA, Ross JA, Fearon KC. Intramyocellular lipid droplets increase with progression of cachexia in cancer patients. J Cachexia Sarcopenia Muscle 2011; 2: 111-117.
55. Natarajan A, Lemos DR, Rossi FM. Fibro/adipogenic progenitors: a double-edged sword in skeletal muscle regeneration. Cell Cycle 2010; 9: 2045-2046.
56. Vettor R, Milan G, Franzin C, Sanna M, De Coppi P, Rizzuto R et al. The origin of intermuscular adipose tissue and its pathophysiological implications. Am J Physiol Endocrinol Metab 2009; 297: E987-E998.
57. Goodpaster BH, Thaete FL, Kelley DE. Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus. Am J Clin Nutr 2000; 71: 885-892.
58. Hilton TN, Tuttle LJ, Bohnert KL, Mueller MJ, Sinacore DR. Excessive adipose tissue infiltration in skeletal muscle in individuals with obesity, diabetes mellitus, and peripheral neuropathy: association with performance and function. Phys Ther 2008; 88: 1336-1344.
59. Uezumi A, Ikemoto-Uezumi M, Tsuchida K. Roles of nonmyogenic mesenchymal progenitors in pathogenesis and regeneration of skeletal muscle. Front Physiol 2014; 5: 68.
60. Moyer AL, Wagner KR. Regeneration versus fibrosis in skeletal muscle. Curr Opin Rheumatol 2011; 23: 568-573.
61. Serrano AL, Mann CJ, Vidal B, Ardite E, Perdiguero E, Munoz-Canoves P. Cellular and molecular mechanisms regulating fibrosis in skeletal muscle repair and disease. Curr Top Dev Biol 2011; 96: 167-201.
62. Tidball JG, Dorshkind K, Wehling-Henricks M. Shared signaling systems in myeloid cellmediated muscle regeneration. Development 2014; 141: 1184-1196.
63. Paylor B, Natarajan A, Zhang RH, Rossi F. Nonmyogenic cells in skeletal muscle regeneration. Curr Top Dev Biol 2011; 96: 139-165.
64. Bentzinger CF, Wang YX, Dumont NA, Rudnicki MA. Cellular dynamics in the muscle satellite cell niche. EMBO Rep 2013; 14: 1062-1072.
65. Madaro L, Bouche M. From innate to adaptive immune response in muscular dystrophies and skeletal muscle regeneration: the role of lymphocytes. Biomed Res Int 2014; 2014: 438675.
66. Judson RN, Zhang RH, Rossi FM. Tissue resident mesenchymal stem/progenitor cells in skeletal muscle: collaborators or saboteurs? FEBS J 2013; 280: 4100-4108.
67. Uezumi A, Ito T, Morikawa D, Shimizu N, Yoneda T, Segawa M et al. Fibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscle. J Cell Sci 2011; 124: 3654-3664.
68. Forcales SV, Albini S, Giordani L, Malecova B, Cignolo L, Chernov A et al. Signal-dependent incorporation of MyoD-BAF60c into Brg1-based SWI/SNF chromatin-remodelling complex. EMBO J 2012; 31: 301-316.
69. Cacchiarelli D, Martone J, Girardi E, Cesana M, Incitti T, Morlando M et al. MicroRNAs involved in molecular circuitries relevant for the Duchenne muscular dystrophy pathogenesis are controlled by the dystrophin/nNOS pathway. Cell Metab 2010; 12: 341-351.
70. Colussi C, Mozzetta C, Gurtner A, Illi B, Rosati J, Straino S et al. HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment. Proc Natl Acad Sci USA 2008; 105: 19183-19187.
71. Biressi S, Miyabara EH, Gopinath SD, Carlig PM, Rando TA. A Wnt-TGFbeta2 axis induces a fibrogenic program in muscle stem cells from dystrophic mice. Sci Transl Med 2014; 6: 267ra176.
72. Degens H. The role of systemic inflammation in age-related muscle weakness and wasting. Scand J Med Sci Sports 2010; 20: 28-38.
73. Peake J, Della GP, Cameron-Smith D. Aging and its effects on inflammation in skeletal muscle at rest and following exercise-induced muscle injury. Am J Physiol Regul Integr Comp Physiol 2010; 298: R1485-R1495.
74. Gopinath SD, Rando TA. Stem cell review series: aging of the skeletal muscle stem cell niche. Aging Cell 2008; 7: 590-598.
75. Chakkalakal JV, Jones KM, Basson MA, Brack AS. The aged niche disrupts muscle stem cell quiescence. Nature 2012; 490: 355-360.
76. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 2005; 433: 760-764.
77. Cosgrove BD, Gilbert PM, Porpiglia E, Mourkioti F, Lee SP, Corbel SY et al. Rejuvenation of the muscle stem cell population restores strength to injured aged muscles. Nat Med 2014; 20: 255-264.
78. Bernet JD, Doles JD, Hall JK, Kelly Tanaka K, Carter TA, Olwin BB. p38 MAPK signaling underlies a cell-autonomous loss of stem cell self-renewal in skeletal muscle of aged mice. Nat Med 2014; 20: 265-271.
79. Carlson ME, Hsu M, Conboy IM. Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells. Nature 2008; 454: 528-532.
80. Carlson ME, Suetta C, Conboy MJ, Aagaard P, Mackey A, Kjaer M et al. Molecular aging and rejuvenation of human muscle stem cells. EMBO Mol Med 2009; 1: 381-391.
81. Sousa-Victor P, Gutarra S, Garcia-Prat L, Rodriguez-Ubreva J, Ortet L, Ruiz-Bonilla V et al. Geriatric muscle stem cells switch reversible quiescence into senescence. Nature 2014; 20506: 316-321.
82. Barberi L, Scicchitano BM, De Rossi M, Bigot A, Duguez S, Wielgosik A et al. Age-dependent alteration in muscle regeneration: the critical role of tissue niche. Biogerontology 2013; 14: 273-292.
83. Elabd C, Cousin W, Upadhyayula P, Chen RY, Chooljian MS, Li J et al. Oxytocin is an age-specific circulating hormone that is necessary for muscle maintenance and regeneration. Nat Commun 2014; 5: 4082.
84. Sinha M, Jang YC, Oh J, Khong D, Wu EY, Manohar R et al. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science 2014; 344: 649-652.
85. Egerman MA, Cadena SM, Gilbert JA, Meyer A, Nelson HN, Swalley SE et al. GDF11 increases with age and inhibits skeletal muscle regeneration. Cell Metab 2015; 22: 164-174.
86. Verdijk LB, Koopman R, Schaart G, Meijer K, Savelberg HH, van Loon LJ. Satellite cell content is specifically reduced in type II skeletal muscle fibers in the elderly. Am J Physiol Endocrinol Metab 2007; 292: E151-E157.
87. Verdijk LB, Snijders T, Drost M, Delhaas T, Kadi F, van Loon LJ. Satellite cells in human skeletal muscle; from birth to old age. Age (Dordr) 2014; 36: 545-547.
88. Snijders T, Verdijk LB, Smeets JS, McKay BR, Senden JM, Hartgens F et al. The skeletal muscle satellite cell response to a single bout of resistance-type exercise is delayed with aging in men. Age 2014; 36: 9699.
89. Verdijk LB, Gleeson BG, Jonkers RAM, Meijer K, HHCM Savelberg, Dendale P et al. Skeletal muscle hypertrophy following resistance training is accompanied by a fiber type-specific increase in satellite cell content in elderly men. J Gerontol A Biol Sci Med Sci 2009; 64A: 332-339.
90. Mackey AL, Karlsen A, Couppe C, Mikkelsen UR, Nielsen RH, Magnusson SP et al. Differential satellite cell density of type I and II fibres with lifelong endurance running in old men. Acta Physiol (Oxf) 2014; 210: 612-627.
91. Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell 2012; 148: 852-871.
92. Leenders M, Verdijk LB, van der Hoeven L, Adam JJ, van Kranenburg J, Nilwik R et al. Patients with type 2 diabetes show a greater decline in muscle mass, muscle strength, and functional capacity with aging. J Am Med Dir Assoc 2013; 14: 585-592.
93. Goodpaster BH, Chomentowski P, Ward BK, Rossi A, Glynn NW, Delmonico MJ et al. Effects of physical activity on strength and skeletal muscle fat infiltration in older adults: a randomized controlled trial. J Appl Physiol 2008; 105: 1498-1503.
94. Shulman GI. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med 2014; 371: 1131-1141.
95. Schrauwen-Hinderling VB, Hesselink MK, Schrauwen P, Kooi ME. Intramyocellular lipid content in human skeletal muscle. Obesity 2006; 14: 357-367.
96. Goodpaster BH, He J, Watkins S, Kelley DE. Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab 2001; 86: 5755-5761.
97. Amati F, Dube JJ, Alvarez-Carnero E, Edreira MM, Chomentowski P, Coen PM et al. Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes? Diabetes 2011; 60: 2588-2597.
98. Scarda A, Franzin C, Milan G, Sanna M, Dal Pra C, Pagano C et al. Increased adipogenic conversion of muscle satellite cells in obese Zucker rats. Int J Obes (Lond) 2010; 34: 1319-1327.
99. Agley CC, Rowlerson AM, Velloso CP, Lazarus NR, Harridge SD. Human skeletal muscle fibroblasts, but not myogenic cells, readily undergo adipogenic differentiation. J Cell Sci 2013; 126: 5610-5625.
100. Rodgers JT, King KY, Brett JO, Cromie MJ, Charville GW, Maguire KK et al. mTORC1 controls the adaptive transition of quiescent stem cells from G0 to GAlert. Nature 2014; 510: 393-396.
101. Arrighi N, Moratal C, Clement N, Giorgetti-Peraldi S, Peraldi P, Loubat A et al. Characterization of adipocytes derived from fibro/adipogenic progenitors resident in human skeletal muscle. Cell Death Dis 2015; 6: e1733.
102. Chang YH, Ho KT, Lu SH, Huang CN, Shiau MY. Regulation of glucose/lipid metabolism and insulin sensitivity by interleukin-4. Int J Obes (Lond) 2012; 36: 993-998.
103. Ho KT, Shiau MY, Chang YH, Chen CM, Yang SC, Huang CN. Association of interleukin-4 promoter polymorphisms in Taiwanese patients with type 2 diabetes mellitus. Metabolism 2010; 59: 1717-1722.
104. Tsao CH, Shiau MY, Chuang PH, Chang YH, Hwang J. Interleukin-4 regulates lipid metabolism by inhibiting adipogenesis and promoting lipolysis. J Lipid Res 2014; 55: 385-397.
105. Sun K, Kusminski CM, Scherer PE. Adipose tissue remodeling and obesity. J Clin Invest 2011; 121: 2094-2101.
106. Fink LN, Oberbach A, Costford SR, Chan KL, Sams A, Bluher M et al. Expression of anti-inflammatory macrophage genes within skeletal muscle correlates with insulin sensitivity in human obesity and type 2 diabetes. Diabetologia 2013; 56: 1623-1628.
107. Mikkelsen UR, Couppe C, Karlsen A, Grosset JF, Schjerling P, Mackey AL et al. Life-long endurance exercise in humans: circulating levels of inflammatory markers and leg muscle size. Mech Ageing Dev 2013; 134: 531-540.
108. Ferraz-Amaro I, Gonzalez-Juanatey C, Lopez-Mejias R, Riancho-Zarrabeitia L, Gonzalez-Gay MA. Metabolic syndrome in rheumatoid arthritis. Mediators Inflamm 2013; 2013: 710928.
109. Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D et al. Cachexia: a new definition. Clin Nutr 2008; 27: 793-799.
110. Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab 2009; 94: 2692-2701.
111. Lamas AM, Leon OG, Schleimer RP. Glucocorticoids inhibit eosinophil responses to granulocyte-macrophage colony-stimulating factor. J Immunol 1991; 147: 254-259.
112. Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005; 82: 53-59.
113. Gonzalez MC, Pastore CA, Orlandi SP, Heymsfield SB. Obesity paradox in cancer: new insights provided by body composition. Am J Clin Nutr 2014; 99: 999-1005.
114. Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, McCargar LJ et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 2013; 31: 1539-1547.
115. Silver HJ, Dietrich MS, Murphy BA. Changes in body mass, energy balance, physical function, and inflammatory state in patients with locally advanced head and neck cancer treated with concurrent chemoradiation after low-dose induction chemotherapy. Head Neck 2007; 29: 893-900.
116. Antoun S, Birdsell L, Sawyer MB, Venner P, Escudier B, Baracos VE. Association of skeletal muscle wasting with treatment with sorafenib in patients with advanced renal cell carcinoma: results from a placebo-controlled study. J Clin Oncol 2010; 28: 1054-1060.
117. Gilliam LA, St Clair DK. Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress. Antioxid Redox Signal 2011; 15: 2543-2563.
118. Haseen F, Murray LJ, Cardwell CR, O'Sullivan JM, Cantwell MM. The effect of androgen deprivation therapy on body composition in men with prostate cancer: systematic review and meta-analysis. J Cancer Surviv 2010; 4: 128-139.
119. Visovsky C. Muscle strength, body composition, and physical activity in women receiving chemotherapy for breast cancer. Integr Cancer Ther 2006; 5: 183-191.
120. Murphy KT, Lynch GS. Update on emerging drugs for cancer cachexia. Expert Opin Emerg Drugs 2009; 14: 619-632.
121. Antoun S, Baracos VE, Birdsell L, Escudier B, Sawyer MB. Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma. Ann Oncol 2010; 21: 1594-1598.
122. Ross PJ, Ashley S, Norton A, Priest K, Waters JS, Eisen T et al. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer 2004; 90: 1905-1911.
123. Massicotte MH, Borget I, Broutin S, Baracos VE, Leboulleux S, Baudin E et al. Body composition variation and impact of low skeletal muscle mass in patients with advanced medullary thyroid carcinoma treated with vandetanib: results from a placebo-controlled study. J Clin Endocrinol Metab 2013; 98: 2401-2408.
124. Prado CM, Baracos VE, McCargar LJ, Reiman T, Mourtzakis M, Tonkin K et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 2009; 15: 2920-2926.
125. He WA, Berardi E, Cardillo VM, Acharyya S, Aulino P, Thomas-Ahner J et al. NF-kappaB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia. J Clin Invest 2013; 123: 4821-4835.
126. Palacios D, Mozzetta C, Consalvi S, Caretti G, Saccone V, Proserpio V et al. TNF/p38alpha/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration. Cell Stem Cell 2010; 7: 455-469.
127. Roberts EW, Deonarine A, Jones JO, Denton AE, Feig C, Lyons SK et al. Depletion of stromal cells expressing fibroblast activation protein-alpha from skeletal muscle and bone marrow results in cachexia and anemia. J Exp Med 2013; 210: 1137-1151.
128. Mason JC, Libby P. Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions. Eur Heart J 2015; 36: 482-9c.
129. Ekblom B, Lovgren O, Alderin M, Fridstrom M, Satterstrom G. Physical performance in patients with rheumatoid arthritis. Scand J Rheumatol 1974; 3: 121-125.
130. Hsieh LF, Didenko B, Schumacher Jr HR, Torg JS. Isokinetic and isometric testing of knee musculature in patients with rheumatoid arthritis with mild knee involvement. Arch Phys Med Rehabil 1987; 68: 294-297.
131. Ekdahl C, Broman G. Muscle strength, endurance, and aerobic capacity in rheumatoid arthritis: a comparative study with healthy subjects. Ann Rheum Dis 1992; 51: 35-40.
132. Hakkinen A, Hannonen P, Hakkinen K. Muscle strength in healthy people and in patients suffering from recent-onset inflammatory arthritis. Br J Rheumatol 1995; 34: 355-360.
133. Nordesjo LO, Nordgren B, Wigren A, Kolstad K. Isometric strength and endurance in patients with severe rheumatoid arthritis or osteoarthrosis in the knee joints. A comparative study in healthy men and women. Scand J Rheumatol 1983; 12: 152-156.
134. Beenakker KG, Ling CH, Meskers CG, de Craen AJ, Stijnen T, Westendorp RG et al. Patterns of muscle strength loss with age in the general population and patients with a chronic inflammatory state. Ageing Res Rev 2010; 9: 431-436.
135. Magyar E, Talerman A, Mohacsy J, Wouters HW, de Bruijn WC. Muscle changes in rheumatoid arthritis. A review of the literature with a study of 100 cases. Virchows Arch A Pathol Anat Histol 1977; 373: 267-278.
136. Beenakker KG, Duijnisveld BJ, Van Der Linden HM, Visser CP, Westendorp RG, Butler-Brown G et al. Muscle characteristics in patients with chronic systemic inflammation. Muscle Nerve 2012; 46: 204-209.
137. Duijnisveld BJ, Bigot A, Beenakker KG, Portilho DM, Raz V, van der Heide HJ et al. Regenerative potential of human muscle stem cells in chronic inflammation. Arthritis Res Ther 2011; 13: R207.
138. Mathur S, Brooks D, Carvalho CR. Structural alterations of skeletal muscle in COPD. Front Physiol 2014; 5: 104.
139. Allaire J, Maltais F, LeBlanc P, Simard PM, Whittom F, Doyon JF et al. Lipofuscin accumulation in the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Muscle Nerve 2002; 25: 383-389.
140. Folkesundhedsrapporten (Kronisk Obstruktiv Lungesygdom), Danmark Statens Institut for Folkesundhed 2007.
141. Theriault ME, Pare ME, Lemire BB, Maltais F, Debigare R. Regenerative defect in vastus lateralis muscle of patients with chronic obstructive pulmonary disease. Respir Res 2014; 15: 35.
142. Theriault ME, Pare ME, Maltais F, Debigare R. Satellite cells senescence in limb muscle of severe patients with COPD. PLoS One 2012; 7: e39124.
143. Kadi F, Schjerling P, Andersen LL, Charifi N, Madsen JL, Christensen LR et al. The effects of heavy resistance training and detraining on satellite cells in human skeletal muscles. J Physiol 2004; 558: 1005-1012.
144. Mackey AL, Holm L, Reitelseder S, Pedersen TG, Doessing S, Kadi F et al. Myogenic response of human skeletal muscle to 12 weeks of resistance training at light loading intensity. Scand J Med Sci Sports 2010; 21: 773-782.
145. Mikkelsen UR, Langberg H, Helmark IC, Skovgaard D, Andersen LL, Kjaer M et al. Local NSAID infusion inhibits satellite cell proliferation in human skeletal muscle after eccentric exercise. J Appl Physiol 2009; 107: 1600-1611.
146. Farup J, Rahbek SK, Riis S, Vendelbo MH, Paoli F, Vissing K. Influence of exercise contraction mode and protein supplementation on human skeletal muscle satellite cell content and muscle fiber growth. J Appl Physiol 2014; 117: 898-909.
147. Farup J, Rahbek SK, Knudsen IS, de Paoli F, Mackey AL, Vissing K. Whey protein supplementation accelerates satellite cell proliferation during recovery from eccentric exercise. Amino Acids 2014; 46: 2503-2516.
148. Ryall James G, Dell'Orso S, Derfoul A, Juan A, Zare H, Feng X et al. The NAD+-dependent SIRT1 deacetylase translates a metabolic switch into regulatory epigenetics in skeletal muscle stem cells. Cell Stem Cell 2015; 16: 171-183.
149. Tang AH, Rando TA. Induction of autophagy supports the bioenergetic demands of quiescent muscle stem cell activation. EMBO J 2014; 33: 2782-2797.
150. Tedesco FS, Dellavalle A, Diaz-Manera J, Messina G, Cossu G. Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. J Clin Invest 2010; 120: 11-19.
151. Sambasivan R, Yao R, Kissenpfennig A, Van Wittenberghe L, Paldi A, Gayraud-Morel B et al. Pax7-expressing satellite cells are indispensable for adult skeletal muscle regeneration. Development 2011; 138: 3647-3656.
152. Montarras D, L'Honore A, Buckingham M. Lying low but ready for action: the quiescent muscle satellite cell. FEBS J 2013; 280: 4036-4050.
153. Konigsberg UR, Lipton BH, Konigsberg IR. The regenerative response of single mature muscle fibers isolated in vitro. Dev Biol 1975; 45: 260-275.
154. O'Connor RS, Pavlath GK. Point: counterpoint: satellite cell addition is/is not obligatory for skeletal muscle hypertrophy. J Appl Physiol 2007; 103: 1099-1100.
155. Brack AS, Rando TA. Tissue-specific stem cells: lessons from the skeletal muscle satellite cell. Cell Stem Cell 2012; 10: 504-514.
156. Rosenblatt JD, Parry DJ. Gamma irradiation prevents compensatory hypertrophy of overloaded mouse extensor digitorum longus muscle. J Appl Physiol 1992; 73: 2538-2543.
157. Adams GR, Caiozzo VJ, Haddad F, Baldwin KM. Cellular and molecular responses to increased skeletal muscle loading after irradiation. Am J Physiol Cell Physiol 2002; 283: C1182-C1195.
158. Blaauw B, Reggiani C. The role of satellite cells in muscle hypertrophy. J Muscle Res Cell Motil 2014; 35: 3-10.
159. Guerci A, Lahoute C, Hebrard S, Collard L, Graindorge D, Favier M et al. Srf-dependent paracrine signals produced by myofibers control satellite cell-mediated skeletal muscle hypertrophy. Cell Metab 2012; 15: 25-37.
160. Lee S, Barton ER, Sweeney HL, Farrar RP. Viral expression of insulin-like growth factor-I enhances muscle hypertrophy in resistance-trained rats. J Appl Physiol 2004; 96: 1097-1104.
161. Barton-Davis ER, Shoturma DI, Sweeney HL. Contribution of satellite cells to IGF-I induced hypertrophy of skeletal muscle. Acta Physiol Scand 1999; 167: 301-305.
162. McKay BR, O'Reilly CE, Phillips SM, Tarnopolsky MA, Parise G. Co-expression of IGF-1 family members with myogenic regulatory factors following acute damaging muscle-lengthening contractions in humans. J Physiol 2008; 586: 5549-5560.
163. Snijders T, Verdijk LB, McKay BR, Smeets JSJ, van Kranenburg J, Groen BBB et al. Acute dietary protein intake restriction is associated with changes in myostatin expression after a single bout of resistance exercise in healthy young men. J Nutr 2013; 144: 137-145.
164. Snijders T, Verdijk LB, Beelen M, McKay BR, Parise G, Kadi F et al. A single bout of exercise activates skeletal muscle satellite cells during subsequent overnight recovery. Exp Physiol 2012; 97: 762-773.
165. Mackey AL, Esmarck B, Kadi F, Koskinen SO, Kongsgaard M, Sylvestersen A et al. Enhanced satellite cell proliferation with resistance training in elderly men and women. Scand J Med Sci Sports 2007; 17: 34-42.
166. Mackey AL, Andersen LL, Frandsen U, Sjogaard G. Strength training increases the size of the satellite cell pool in type I and II fibres of chronically painful trapezius muscle in females. J Physiol 2011; 589: 5503-5515.
167. Olsen S, Aagaard P, Kadi F, Tufekovic G, Verney J, Olesen JL et al. Creatine supplementation augments the increase in satellite cell and myonuclei number in human skeletal muscle induced by strength training. J Physiol 2006; 573: 525-534.
168. Petrella JK, Kim JS, Mayhew DL, Cross JM, Bamman MM. Potent myofiber hypertrophy during resistance training in humans is associated with satellite cell-mediated myonuclear addition: a cluster analysis. J Appl Physiol 2008; 104: 1736-1742.
169. Verdijk LB, Gleeson BG, Jonkers RA, Meijer K, Savelberg HH, Dendale P et al. Skeletal muscle hypertrophy following resistance training is accompanied by a fiber type-specific increase in satellite cell content in elderly men. J Gerontol A Biol Sci Med Sci 2009; 64: 332-339.
170. Paulsen G, Mikkelsen UR, Raastad T, Peake JM. Leucocytes cytokines and satellite cells: what role do they play in muscle damage and regeneration following eccentric exercise? Exerc Immunol Rev 2012; 18: 42-97.
171. Taaffe DR, Henwood TR, Nalls MA, Walker DG, Lang TF, Harris TB. Alterations in muscle attenuation following detraining and retraining in resistance-trained older adults. Gerontology 2009; 55: 217-223.
172. Lee SD, Tontonoz P. Eosinophils in fat: pink is the new brown. Cell 2014; 157: 1249-1250.
173. Lancaster GI, Febbraio MA. The immunomodulating role of exercise in metabolic disease. Trends Immunol 2014; 35: 262-269.
174. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
175. Devlin JT, Horton ES. Effects of prior high-intensity exercise on glucose metabolism in normal and insulin-resistant men. Diabetes 1985; 34: 973-979.
176. Henriksen EJ. Invited review: effects of acute exercise and exercise training on insulin resistance. J Appl Physiol 2002; 93: 788-796.
177. Christensen B, Nellemann B, Larsen MS, Thams L, Sieljacks P, Vestergaard PF et al. Whole body metabolic effects of prolonged endurance training in combination with erythropoietin treatment in humans: a randomized placebo controlled study. Am J Physiol Endocrinol Metab 2013; 305: E879-E889.
178. Krogh-Madsen R, Pedersen M, Solomon TP, Knudsen SH, Hansen LS, Karstoft K et al. Normal physical activity obliterates the deleterious effects of a high-caloric intake. J Appl Physiol 2014; 116: 231-239.
179. Charifi N, Kadi F, Feasson L, Denis C. Effects of endurance training on satellite cell frequency in skeletal muscle of old men. Muscle Nerve 2003; 28: 87-92.
180. Verney J, Kadi F, Charifi N, Feasson L, Saafi MA, Castells J et al. Effects of combined lower body endurance and upper body resistance training on the satellite cell pool in elderly subjects. Muscle Nerve 2008; 38: 1147-1154.
181. Fry CS, Noehren B, Mula J, Ubele MF, Westgate PM, Kern PA et al. Fibre type-specific satellite cell response to aerobic training in sedentary adults. J Physiol 2014; 592: 2625-2635.
182. Snijders T, Verdijk LB, Hansen D, Dendale P, van Loon LJ. Continuous endurance-type exercise training does not modulate satellite cell content in obese type 2 diabetes patients. Muscle Nerve 2011; 43: 393-401.
183. Malecova B, Puri PL. "Mix of Mics"-phenotypic and biological heterogeneity of "Multipotent" muscle interstitial cells (MICs). J Stem Cell Res Ther 2012; e-pub ahead of print 17 October 2012.